Lyrica (Pregabalin) for Myeloma

Overview
Lyrica is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat fibromyalgia, postherpetic neuralgia, partial onset seizures, and neuropathic pain associated with diabetic neuropathy and spinal cord injuries. Lyrica is sometimes prescribed to treat neuropathic pain—a common side effect of treatment—in people with myeloma. Lyrica is also referred to by its drug name, pregabalin.

Lyrica is an analgesic and anticonvulsant. Lyrica is believed to work on certain types of pain by reducing pain signals sent by damaged nerves.

How do I take it?
Prescribing information states that Lyrica should be taken orally two or three times a day with or without food.

Lyrica comes in capsule and liquid solution form.

Side effects
The FDA-approved label for Lyrica lists common side effects including dizziness, drowsiness, dry mouth, weight gain, blurry vision, swelling of the hands and feet, and difficulty concentrating.

Rare but serious side effects listed for Lyrica include suicidal thoughts, hypersensitivity, respiratory depression, swelling in the head and neck, seizures, and systemic allergic reaction.

For more details about this treatment, visit:

Lyrica — Viatris
http://www.lyrica.com

Supportive Care for Multiple Myeloma — Canadian Cancer Society
https://www.cancer.ca/en/region-selector-page/?...